February 2024

MIMS Full Prescribing Update

New / Revised

Product Name

Section changed
New Adalicip
New Apretude
New Aqium Moisturising Gel
New Codral ActiRelief Sore Throat Lozenges
New Codral Cold & Flu
New Codral Cold & Flu + Dry Cough
New Codral Cold & Flu + Mucus Cough
New Codral Day & Night
New Codral Dry Cough + Cold
New Codral Duo Relief Sore Throat Lozenges
New Codral Mucus Cough
New Codral Mucus Cough Forte Strength
New Codral Night
New Codral Sore Throat Lozenges
New Ferrous + C
New Ferrous + C Chewable
New Gentamicin Noridem
New Kimmtrak
New MagZorb
New Melatonin MR-Teva
New Metronidazole Noridem
New Pharmacor Deferasirox
New Pharmacy Action Cold & Flu + Cough Day & Night
New Pharmacy Action Magnesium High Dose 1-a-Day
New Pirfenidet
New Ramipril Viatris
New Sitagliptin/Metformin Sandoz XR
New Sugammadex ARX
New Sumagraine Migraine Relief
New Tiotropium Lupin
New Trazent
New Zoledronate-DRLA 4
Reinstated Rosalee
Reinstated Rosie
Revised Adrenaline Aguettant TGA Date
Revised AKM Fingolimod TGA Date
Revised Alfentanil GH Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Alprim Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Alziras Sponsor
Revised AmBisome Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties
Revised Anagraine Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, New contraindication, Overdose, Special Warnings and Precautions for Use
Revised Apidra TGA Date
Revised APO-Azathioprine Sponsor
Revised APO-Dimethyl Fumarate Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised APO-Fluoxetine (was Fluoxetine APOTEX) Special Warnings and Precautions for Use
Revised APO-Fluvoxamine Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised APO-Irbesartan HCTZ Qualitative and Quantitative Composition, Special Precautions for Storage
Revised APO-Isotretinoin List of Excipients, Sponsor
Revised Apomine Solution for Infusion Sponsor
Revised APO-Pramipexole Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised APO-Simvastatin Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised APX-Escitalopram Nature and Contents of Container, Pharmaceutical Form
Revised ARX-Glimepiride (was Glimepiride APOTEX) Product Name change
Revised ARX-Lercanidipine Qualitative and Quantitative Composition, Sponsor
Revised Avsartan HCT Sponsor
Revised Azathioprine GH Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Azathioprine Sandoz Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Bella Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Blooms the Chemist Irbesartan HCTZ Qualitative and Quantitative Composition, Special Precautions for Storage
Revised Blooms the Chemist Paroxetine Special Warnings and Precautions for Use
Revised Botox Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties
Revised Bridion Pharmacological Properties
Revised Brukinsa Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised BTC Ezetimibe Adverse Effects (Undesirable Effects)
Revised BTC Fluoxetine Special Warnings and Precautions for Use
Revised Bupredermal Nature and Contents of Container
Revised Carbetocin Interpharma Product Name change
Revised Cephazolin Viatris Nature and Contents of Container
Revised Comirnaty Omicron XBB.1.5 Dose and Method of Administration, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Shelf Life, Therapeutic Indications
Revised Comirnaty Original/Omicron BA.4-5 Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Shelf Life, Special Precautions for Storage, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Cresemba Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties
Revised Dasatinib ARX Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised DBL Amikacin Injection Special Warnings and Precautions for Use
Revised Dexdor Adverse Effects (Undesirable Effects), Dose and Method of Administration, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Dexmedetomidine Sandoz Adverse Effects (Undesirable Effects), Dose and Method of Administration, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Dexmedetomidine Viatris Adverse Effects (Undesirable Effects), Dose and Method of Administration, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Diabex Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Eleanor 150/30 ED Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Eleva Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Eloctate Deleted Presentation, Nature and Contents of Container, Qualitative and Quantitative Composition
Revised Endoxan TGA Date
Revised Entyvio Special Warnings and Precautions for Use
Revised Ephedrine Interpharma Product Name change
Revised Epilim Nature and Contents of Container
Revised Erlotinib ARX (was Erlotinib Apotex) Product Name change
Revised Esipram Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Evenity Adverse Effects (Undesirable Effects), New contraindication, Special Warnings and Precautions for Use
Revised Evrysdi Adverse Effects (Undesirable Effects), Pharmacological Properties
Revised Ezetimibe Sandoz Adverse Effects (Undesirable Effects)
Revised Fasturtec TGA Date
Revised Fenpatch Overdose
Revised Fentanyl Juno Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Fiasp TGA Date
Revised Flecatab Qualitative and Quantitative Composition
Revised Fluarix Tetra Qualitative and Quantitative Composition
Revised Fluotex Special Warnings and Precautions for Use, Sponsor
Revised Hadlima TGA Date
Revised Hemlibra TGA Date
Revised Hydroxychloroquine GH Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Ibrance Pharmacological Properties
Revised Implanon NXT Adverse Effects (Undesirable Effects)
Revised Increlex Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Ipol Qualitative and Quantitative Composition
Revised Isabelle Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Lemtrada TGA Date
Revised Linevox Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Lorstat List of Excipients, Nature and Contents of Container
Revised MabCampath TGA Date
Revised Maxolon Contraindications, Deleted Presentation, Dose and Method of Administration, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Metalyse Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Precautions for Storage, Special Warnings and Precautions for Use
Revised Methotrexate Ebewe Adverse Effects (Undesirable Effects), Boxed Warnings, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Micardis Plus Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Pharmacological Properties
Revised Minomycin 50 Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Product Name change, Special Warnings and Precautions for Use
Revised Mounjaro Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Mycobutin Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use
Revised Myozyme TGA Date
Revised Nicotinic Acid Nature and Contents of Container, Pharmaceutical Form
Revised Norspan Nature and Contents of Container
Revised Omnipaque (Intrathecal) TGA Date, TGA Date
Revised Omnipaque (Intravascular, Oral and Body Cavities) TGA Date, TGA Date
Revised Oxyndone Overdose
Revised Parlodel TGA Date
Revised Phebra Calcium Gluconate 931 mg/10 mL Injection Nature and Contents of Container, Special Warnings and Precautions for Use
Revised Phenobarbitone Injection (Aspen Pharmacare) Adverse Effects (Undesirable Effects)
Revised Phentodur Sponsor
Revised Plavicor 75 Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Puregon Adverse Effects (Undesirable Effects)
Revised Recagon Adverse Effects (Undesirable Effects)
Revised Renflexis TGA Date
Revised Rosuvastatin Lupin Interactions with Other Medicines and Other Forms of Interactions
Revised Rosuvastatin Sandoz Interactions with Other Medicines and Other Forms of Interactions
Revised Rozlytrek Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Sandrena Interactions with Other Medicines and Other Forms of Interactions
Revised Scemblix Nature and Contents of Container, Special Precautions for Storage
Revised Sifrol and Sifrol ER Adverse Effects (Undesirable Effects)
Revised Sildenafil PHT APOTEX Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Simpral Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Simvar Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Sinemet Dose and Method of Administration, Pharmaceutical Form
Revised Sitagliptin/Metformin Sandoz New Brand of Product already available, TGA Date
Revised Spinraza Fertility, Pregnancy and Lactation, Pharmacological Properties
Revised Tegretol Nature and Contents of Container
Revised Thioprine 50 Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Tobramycin WKT Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Toujeo TGA Date
Revised Tranexamic Acid LU Contraindications, Dose and Method of Administration, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Transiderm-Nitro TGA Date
Revised Trimethoprim Viatris Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Truxima Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Ultravist Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, New contraindication, New indication, Pharmacological Properties
Revised Uptravi Adverse Effects (Undesirable Effects), Pharmacological Properties
Revised Vaclovir Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Valaciclovir Sandoz Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Valproate Winthrop Nature and Contents of Container
Revised Vancomycin Juno Adverse Effects (Undesirable Effects)
Revised Vancomycin Juno (Old Formulation) Adverse Effects (Undesirable Effects)
Revised Vesanoid Pharmaceutical Form, Qualitative and Quantitative Composition
Revised Voxzogo Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Vttack Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Vyxeos Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Xeomin TGA Date
Revised Xylocard TGA Date
Revised Zedace Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions
Revised Zimybe Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions
Deleted Byetta
Deleted Capoten
Deleted Cipla Deferasirox
Deleted DBL Hyoscine Injection BP
Deleted Gabapentin APOTEX Capsules
Deleted Jamp-Cholestyramine
Deleted Jurnista
Deleted Panzytrat 25000 (Allergan)
Deleted Pyridostigmine Bromide Tablets (Rising Pharmaceuticals)
Deleted QuitX Chewing Gum
Deleted QuitX Coated Chewing Gum
Deleted Steglatro
Deleted Zinplava

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Suite 1602, Level 16
44 Market Street
Sydney NSW 2000
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au